These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8282860)

  • 1. Enhanced detection of brain tumors by [18F]fluorodeoxyglucose PET with glucose loading.
    Ishizu K; Sadato N; Yonekura Y; Nishizawa S; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Tanaka F; Miyatake S
    J Comput Assist Tomogr; 1994; 18(1):12-5. PubMed ID: 8282860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hyperglycemia on FDG uptake in human brain and glioma.
    Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
    J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors.
    Schifter T; Hoffman JM; Hanson MW; Boyko OB; Beam C; Paine S; Schold SC; Burger PC; Coleman RE
    J Comput Assist Tomogr; 1993; 17(4):509-61. PubMed ID: 8392523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
    DeLaPaz RL; Patronas NJ; Brooks RA; Smith BH; Kornblith PL; Milam H; Di Chiro G
    AJNR Am J Neuroradiol; 1983; 4(3):826-9. PubMed ID: 6308993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
    Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
    J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
    Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
    J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET in pediatric posterior fossa brain tumors.
    Hoffman JM; Hanson MW; Friedman HS; Hockenberger BM; Oakes WJ; Halperin EC; Coleman RE
    J Comput Assist Tomogr; 1992; 16(1):62-8. PubMed ID: 1729308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
    Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
    J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH; Delbeke D; Patton JA; Sandler MP
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
    Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
    J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors.
    Nelson SJ; Day MR; Buffone PJ; Wald LL; Budinger TF; Hawkins R; Dillon WP; Huhn S; Prados MD; Chang S; Vigneron DB
    J Comput Assist Tomogr; 1997; 21(2):183-91. PubMed ID: 9071283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.